BET inhibitor apabetalone (RVX-208) downregulates the complement cascade in primary human hepatocytes, in mice and in cardiovascular disease human patients. (September 2017)

Record Type:: Journal Article
Title:: BET inhibitor apabetalone (RVX-208) downregulates the complement cascade in primary human hepatocytes, in mice and in cardiovascular disease human patients. (September 2017)
Main Title:: BET inhibitor apabetalone (RVX-208) downregulates the complement cascade in primary human hepatocytes, in mice and in cardiovascular disease human patients
Authors:: Wasiak, Sylwia
Gilham, Dean
Tsujikawa, Laura M.
Halliday, Christopher
Calosing, Cyrus
Jahagirdar, Ravi
Johansson, Jan
Sweeney, Michael
Wong, Norman C.
Kulikowski, Ewelina
Abstract:
Is Part Of:: Molecular immunology. Volume 89(2017:Sep.)
Journal:: Molecular immunology
Issue:: Volume 89(2017:Sep.)
Issue Display:: Volume 89 (2017)
Year:: 2017
Volume:: 89
Issue Sort Value:: 2017-0089-0000-0000
Page Start:: 127
Page End:: 128
Publication Date:: 2017-09
Subjects:: Immunochemistry -- Periodicals
Molecular biology -- Periodicals
Immunochemistry -- Periodicals
Allergy and Immunology -- Periodicals
Molecular Biology -- Periodicals
Immunochimie -- Périodiques
Biologie moléculaire -- Périodiques
Immunochemistry
Molecular biology
Periodicals
Electronic journals
571.96
Journal URLs:: http://www.sciencedirect.com/science/journal/01615890 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.molimm.2017.06.243 ↗
Languages:: English
ISSNs:: 0161-5890
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5900.817700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 4650.xml